1.
Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. Precis. Med. Com. [Internet]. 2022 Jun. 30 [cited 2026 May 8];2(1):27-42. Available from: https://rootspress.org/journals/index.php/PMC/article/view/44